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Introduction
Community-associated methicillin-resistant Staphylococ-
cus aureus (CMRSA) was first reported in Geneva in
2002; a prospective surveillance system based on volun-
tary reporting was then established.
Objectives
We report trends in CMRSA infections in Geneva Can-
ton from 2002 through 2012.
Methods
The Cantonal Antibiotic Resistance Group, representing
Geneva’s Department of Health, University Hospitals and
public and private laboratories, defines a CMRSA case as
(1) a clinical infection from which MRSA is isolated in any
adult or child with (2) no hospitalizations in the previous
12 months (excluding hospital stays for infants at birth),
and (3) residence in Geneva Canton. Four laboratories as
well as physicians from public hospitals and private practice
participate. For each laboratory-reported case, a question-
naire is sent to the clinician for demographic and clinical
information. Contact tracing is performed to detect cluster-
ing. Descriptive analyses were performed using Stata 12.
Results
There were 245 CMRSA cases in the 11-year surveillance
period; the mean attack rate was 4.9 cases/100K inhabi-
tants. Median age at diagnosis was 31 years (interquartile
range, 13–48); 20% were under ten. Skin infections
dominated (82%). There were no cases of necrotizing
pneumonia, fasciitis or infection-related death. Incident
cases predominated (75%); recurrences did not increase
over time. Most infections (75%) occurred in persons
without comorbidity; “chronic dermatologic condition”
was the most common comorbidity (15/48, 31%) followed
by diabetes mellitus (8/48, 17%). Fifty clusters were identi-
fied, most being family-related. After peaking at 8.4 cases/
100K inhabitants in 2005, CMRSA incidence has since
plateaued at a mean of 5.5 cases/100K inhabitants.
Conclusion
After peaking in 2005, CMRSA infections appear to have
stabilized despite continuous introduction of new strains.
The surveillance system and related measures appear to be
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